NCT05195086

A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 122 (actual)
• Sponsor: Nada Magdy Mansour · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: —

Summary

The aim of this study is to conduct a pharmacoeconomic analysis to compare the use of Mycophenolate Mofetil or i.v. Cyclophosphamide as induction therapy from a third party payer perspective in LN patients in the Egyptian context

Conditions

• Lupus Nephritis

Interventions

Type	Name	Description
DRUG	endoxan	Immunosuppressant
DRUG	cellcept	Immunosuppressant

Timeline

• Start date: 2018-07-01
• Primary completion: 2020-01-01
• Completion: 2021-06-05
• First posted: 2022-01-18
• Last updated: 2022-01-18

Locations

1 site across 1 country: Egypt

Regulatory

• FDA-regulated drug study